Sadoff Investment Management’s AbbVie ABBV Stock Holding History

Sadoff Investment Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-2,823	Closed	-$260K	–	88
2018 Q4	$260K	Buy	2,823 +100	+4%	+$8.79K	0.03%	78
2018 Q3	$258K	Sell	2,723 -150	-5%	-$14.2K	0.02%	79
2018 Q2	$266K	Sell	2,873 -1,400	-33%	-$137K	0.02%	78
2018 Q1	$404K	Sell	4,273 -2,400	-36%	-$264K	0.03%	61
2017 Q4	$645K	Buy	+6,673	New	+$629K	0.05%	52
2016 Q4	–	Sell	-5,895	Closed	-$372K	–	75
2016 Q3	$372K	Buy	+5,895	New	+$382K	0.04%	55
2015 Q1	–	Sell	-3,225	Closed	-$211K	–	56
2014 Q4	$211K	Buy	+3,225	New	+$203K	0.02%	55

Other funds holding ABBV

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Sadoff Investment Management's ABBV Position: Q1 2019 in Review

Sadoff Investment Management sold out of AbbVie (ABBV) in Q1 2019, closing a stake of 2,823 shares — an estimated $260K sold.

Sadoff Investment Management first reported a position in ABBV in Q4 2014 and held it in 7 quarters. The position peaked at $645K in Q4 2017. 2,034 funds tracked by Wall St. Rank hold ABBV as of Q1 2019.

Sadoff Investment Management reported no remaining AbbVie position as of Q1 2019 after selling out during the quarter.
Sadoff Investment Management sold 2,823 AbbVie shares in Q1 2019, an estimated $260K.
Sadoff Investment Management first reported a position in AbbVie in Q4 2014 and held it in 7 quarters.
Sadoff Investment Management's AbbVie position peaked at $645K in Q4 2017.
2,034 funds tracked by Wall St. Rank held AbbVie as of Q1 2019.

Based on Sadoff Investment Management's 13F filing for Q1 2019, filed 13 May 2019.